CXC-chemokines, a new group of cytokines in congestive heart failure - Possible role of platelets and monocytes

Cardiovascular Research

Volumn 45, Issue 2, 2000, Pages 428-436

  Damås, Jan Kristian ^a,b   Gullestad, Lars ^a   Ueland, Thor ^a   Solum, Nils Olav ^b   Simonsen, Svein ^a   Frøland, Stig S ^b   Aukrust, Pål ^b  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

Cytokines; Heart failure; Infection inflammation; Leukocytes; Platelets

Indexed keywords

ALPHA CHEMOKINE; EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78; INTERLEUKIN 8;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME IMMUNOASSAY; FEMALE; HUMAN; INFLAMMATION; MALE; MONOCYTE; PATHOGENESIS; PRIORITY JOURNAL; THROMBOCYTE;

ANALYSIS OF VARIANCE; CASE-CONTROL STUDIES; CHEMOKINES, CXC; CHEMOTACTIC FACTORS; FEMALE; GROWTH SUBSTANCES; HEART FAILURE, CONGESTIVE; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; INTERLEUKIN-8; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; PLATELET ACTIVATION; STATISTICS, NONPARAMETRIC;

EID: 0033958006     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(99)00262-X     Document Type: Article

References (43)

1. Levine B., Kalman J., Mayer L., Filit H.M., Packer M. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. New Engl J Med. 323:1990;236-241.
2. Mann D.L., Young J.B. Basic mechanisms in congestive heart failure. Recognizing the role of proinflammatory cytokines. Chest. 105:1994;897-904.
3. 2+ current by interleukin-1β in cultured rat ventricular myocytes. Am J Physiol. 268:1995;C339-C349.
4. Yokoyama T., Vaca L., Rossen R.D., et al. Cellular basis for the negative inotropic effects of tumor necrosis factor-α in the mammalian heart. J Clin Invest. 92:1993;2303-2312.
5. Finkel M.S., Oddis C.V., Jacob T.D., et al. Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science. 257:1992;387-389.
6. Oyama J., Shimokawa H., Momii H., et al. Role of nitric oxide and peroxynitrite in the cytokine-induced sustained myocardial dysfunction in dogs in vivo. J Clin Invest. 101:1998;2207-2214.
7. Krown K.A., Page M.T., Nguyen C., et al. Tumor necrosis factor alpha-induced apoptosis in cardiac myocytes. J Clin Invest. 98:1996;2854-2865.
8. Kunisada K., Hirota H., Fujio Y., et al. Activation of JAK-STAT and MAP kinases by leukaemia inhibitory factor through gp 130 in cardiac myocytes. Circulation. 94:1996;2626-2632.
9. Hirota H., Yoshida K., Kishimoto T., Taga T. Continuous activation of GP 130, a signal-transacting receptor component for interleukin-6 related cytokiner, causes myocardial hypertrophy in mice. Proc Natl Acad Sci U.S.A. 92:1995;4862-4866.
10. Mann D.L. Tumor necrosis factor α and cardiac remodelling. Heart Failure. 11:1995;166-176.
11. Bozkurt B., Kribbs S.B., Clubb F.J., et al. Pathophysiologically relevant concentrations of tumor necrosis factor-α promote progressive left ventricular dysfunction and remodelling in rats. Circulation. 97:1998;1382-1391.
12. Devaux B., Scholz D., Hirche A., Klovekorn W.P., Schaper J. Upregulation of cell adhesion molecules and the presence of low grade inflammation in human chronic heart failure. Eur Heart J. 18:1997;470-479.
13. Aukrust P., Ueland T., Müller F., et al. Elevated circulating levels of C-C chemokines in patients with congestive heart failure. Circulation. 97:1998;1136-1143.
14. Taub D.D., Oppenheim J.J. Chemokines, inflammation and the immune system. Ther Immunol. 1:1994;229-246.
15. Bagglioni M., Dewald B., Moser B. Interleukin-8 and related chemotactic cytokines: CXC and CC-chemokines. Adv Immunol. 55:1994;97-179.
16. Jaeschke H., Smith C.W. Mechanisms of neutrophil-induced parenchymal cell injury. J Leukocyte Biol. 61:1997;647-653.
17. i changes and respiratory burst in human neutrophils and monocytes induced by NAP-1/Interleukin-8, NAP-2 and gro/MGSA. J Leukocyte Biol. 50:1991;279-286.
18. Taub D.D., Anver M., Oppenheim J.J., Longo D.L., Murphy W.J. T lymphocyte recruitment by interleukin-8 (IL-8). J Clin Invest. 97:1996;1931-1941.
19. Kukielka G.L., Youker K.A., Michael L.H., et al. Role of early reperfusion in the induction of adhesion molecules and cytokines in previously ischemic myocardium. Mol Cell Biochem. 147:1995;5-12.
20. Boisvert W.A., Santiago R., Curtiss L.K., Terkeltaub R.A. A leukocyte homologue of the IL-8 receptor CXCR-2 mediates the accumulation of macrophages in atherosclerotic lesions of LDL receptor-deficient mice. J Clin Invest. 101:1998;353-363.
21. Hasper D., Hummel M., Kleber F.X., Reindl I., Volk H.D. Systemic inflammation in patients with heart failure. Eur Heart J. 19:1998;761-765.
22. Goldstein D.J., Moazami N., Seldomridge J.A., et al. Circulatory resuscitation with left ventricular assist device support reduces interleukins 6 and 8 levels. Ann Thorac Surg. 63:1997;971-974.
23. Jafri S.M., Ozawa T., Mammen E., et al. Platelet function, thrombin and fibrinolytic activity in patients with heart failure. Eur Heart J. 14:1993;205-212.
24. Vonhof S., Brost B., Stille-Siegener M., et al. Monocyte activation in congestive heart failure due to coronary artery disease and idiopathic dilated cardiomyopathy. Int J Cardiol. 63:1998;237-244.
25. Holme P.A., Müller F., Solum N.O., et al. Enhanced activation of platelets with abnormal release of RANTES in HIV-1 infection. FASEB J. 12:1998;79-89.
26. Müller F., Rollag H., Gaudernack G., Frøland S.S. Impaired in vitro survival of monocytes from patients with HIV infection. Clin Exp Immunol. 81:1990;25-30.
27. Matsumori A., Ono K., Sato Y., et al. Differential modulation of cytokine production by drugs: implication for therapy in heart failure. J Mol Cell Cardiol. 28:1996;2491-2499.
28. Gullestad L, Aukrust P, Ueland T et al. Decreased interleukin-6 activity during high-dose enalapril therapy. J Am Coll Cardiol, in press.
29. Power C.A., Clementson J.M., Clementson K.J., Wells T.N.C. Chemokine and chemokine receptors mRNA expression in human platelets. Cytokine. 7:1995;479-482.
30. Moriuchi H., Moriuchi M., Fauci A.S. Nuclear factor-κB potently upregulates the promoter activity of RANTES, a chemokine that blocks HIV infection. J Immunol. 158:1997;3483-3491.
31. Niebauer J., Volk H.-D., Kemp M., et al. Endotoxin and immune activation in chronic heart failure: a prospective cohort study. Lancet. 353:1999;1838-1842.
32. Anker S.D., Egerer K.R., Volk H.D., et al. Elevated soluble CD14 receptors and altered cytokines in chronic heart failure. Am J Cardiol. 79:1997;1426-1430.
33. Laurent F., Benoliel A.M., Capo C., Bongrand P. Oxidative metabolism of polymorphonuclear leukocytes: modulation by adhesive stimuli. J Leukocyte Biol. 49:1991;217-226.
34. Su S.-B., Mukaida N., Matsushima K. Rapid secretion of intracellulary pre-stored interleukin-8 from rabbit platelets upon activation. J Leukocyte Biol. 59:1996;420-426.
35. Weyrich A.S., Elstad M.R., McEver R.P., et al. Activated platelets signal chemokine synthesis by human monocytes. J Clin Invest. 97:1996;1525-1534.
36. Neumann F.-J., Marx N., Gawaz M., et al. Induction of cytokine expression in leukocytes by binding of thrombin-stimulated platelets. Circulation. 95:1997;2387-2394.
37. Michelson A.D., Barnard M.R., Hechtman H.B., et al. In vivo tracking of platelets: Circulating degranulated platelets rapidly lose P-selectin but continue to circulate and function. Proc Natl Acad Sci U.S.A. 93:1996;11877-11882.
38. Lundahl T.H., Petersson J., Fagerberg I.H., Berg S., Lindahl T.L. Impaired platelet function correlates with multi-organ dysfunction. A study of patients with sepsis. Platelets. 9:1998;223-225.
39. Lefer A.M., Campbell B., Scalia R., Lefer D.J. Synergism between platelets and neutrophils in provoking cardiac dysfunction after ischemia and reperfusion. Circulation. 98:1998;1322-1328.
40. Iuliano L., Colavita A.R., Leo R., Pratico D., Violi F. Oxygen free radicals and platelet activation. Free Rad Biol Med. 6:1997;999-1006.
41. Neumann F.-J., Ott I., Marx N., et al. Effect of human recombinant interleukin-6 and interleukin-8 on monocyte procoagulant activity. Artherioscler Thromb Vasc Biol. 17:1997;3399-3405.
42. Seino Y., Ikeda U., Sekiguchi H., et al. Expression of leukocyte chemotactic cytokines in myocardial tissue. Cytokines. 7:1995;301-304.
43. Shioi T., Matsumori A., Kihara Y., et al. Increased expression of interleukin-1 beta and monocyte chemotactic and activating factor/monocyte chemoattractant protein-1 in hypertrophied and failing heart with pressure overload. Circ Res. 81:1997;664-671.